中央医院解剖病理学部兼新科研分子与细胞生物学研究院首席科学家杨宝诚博士说，本地有高达70%的肝癌患者五年内病症会复发。“TIMES在预测这些结果方面取得了重大进展，使临床医生能够尽可能提前介入。这将显著提升患者护理质量和存活率。” ...

【导读】肝细胞癌（HCC）是全球癌症相关死亡的主要原因，对全世界的健康造成了重大影响。因此，确定肝细胞癌（HCC）进展的关键分子驱动因素对于改善治疗选择和预后方法至关重要。7月18日，复旦大学/新加坡国立大学/上海交通大学研究人员合作共同在期刊《Jo ...

肝癌是全球范围内常见的恶性肿瘤，而世界上近一半的肝癌病例集中在中国，且大部分与乙型肝炎病毒感染相关[1]。在肝癌的分型中，临床上常依据肿瘤大小将肝癌分为：微小肝癌（直径 ＜ 1 cm）、小肝癌（直径 1-3 cm）、中肝癌（直径 3-5 ...

近期研究已证实放疗在肝细胞癌（HCC）治疗中的重要作用。此前的研究表明，放疗可促进免疫细胞向肿瘤微环境浸润，从而可能增强免疫治疗的效果。基于此，研究人员研究了莲心碱、放疗和免疫治疗联合治疗方案的协同作用。

王玺，研究员，教授，博士生导师。研究方向为肿瘤免疫和感染免疫。现任北京市感染性疾病研究中心-首都医科大学附属北京地坛医院研究所所长，传染病溯源预警与智能决策全国重点实验室PI，首都医科大学肿瘤学系 ...

SINGAPORE, July 21 (Xinhua) -- Singaporean researchers have developed an artificial intelligence-powered scoring system capable of predicting the recurrence of liver cancer, according to a press ...

Researchers validated the system using tissue samples from 231 patients across five hospitals. Further validation studies are ...

There were 74 hepatocellular carcinomas. The sizes of the resected hepatocellular carcinomas ranged from 1.3 cm to 24.0 cm, with a mean of 8.1 cm. Fifty-four (73%) of the tumors were solitary.

Among all resected hepatocellular carcinomas in non-cirrhotic livers over this time period, the prevalence of 16% with HCV infection was significantly greater than that expected by chance.

A 59-year-old man with a history of metabolic dysfunction–associated steatotic liver disease had an enlarging liver mass. Biopsy showed hepatocellular carcinoma. Management decisions were made.